DNA Barcoding‐Enabled Tracking of Lipid Nanoparticles: Drug‐Loading‐Dependent Biodistribution and Tumor Microenvironment Targeting
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202501914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Letao Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Faculty of Science, Engineering and Technology, The University of Adelaide, Adelaide, SA, 5005, Australia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nanoparticles, DNA Barcoding, Taxonomic, Lipids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) are versatile drug delivery systems, yet the impact of drug loading (DL) on their biodistribution and cellular uptake remains poorly understood. Optimizing drug loading is crucial for enhancing therapeutic efficacy and safety, as higher loading allows for lower LNP doses, reducing overall nanomaterial burden. Addressing this knowledge gap is essential for advancing LNP‐based cancer therapies. This study integrates DNA barcoding technology with LNPs to evaluate their in vivo delivery behaviors under varying drug loadings. Using a sequential nanoprecipitation method, DNA‐barcoded LNPs with low (1%), medium (16%), and high (26%) drug loadings are fabricated, each tagged with a unique DNA barcode for precise tracking. Pooled LNPs are intravenously administered to tumor‐bearing mice, and their biodistribution across organs is quantified via qPCR. High drug‐loading LNPs demonstrate preferential accumulation in the spleen, while low drug‐loading LNPs exhibit higher liver accumulation, suggesting faster clearance. Cellular uptake analysis reveals enhanced uptake of high drug‐loading LNPs by tumor‐associated macrophages within the tumor microenvironment (TME). This study establishes a robust platform for simultaneous and high‐sensitivity monitoring of LNP behaviors, significantly reducing animal use and interanimal variability. The findings guide the rational design for developing optimal LNPs for cancer therapies targeting specific TME components.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, Faculty of Science, Engineering and Technology, The University of Adelaide, Adelaide, SA, 5005, Australia.
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia.
ORCID-Profile: Letao Xu, Yun Liu, Chun-Xia Zhao
Förderung
- National Health and Medical Research Council
Zitieren
APA
Xu, L., Chen, R., Wang, X., Liu, D., Liu, Y., & Zhao, C. X. (2025). DNA Barcoding‐Enabled Tracking of Lipid Nanoparticles: Drug‐Loading‐Dependent Biodistribution and Tumor Microenvironment Targeting. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501914
Vancouver
Xu L, Chen R, Wang X, Liu D, Liu Y, Zhao CX. DNA Barcoding‐Enabled Tracking of Lipid Nanoparticles: Drug‐Loading‐Dependent Biodistribution and Tumor Microenvironment Targeting. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501914
BibTeX
@article{Xu2025,
author = {Xu, Letao and Chen, Rui and Wang, Xing and Liu, Dawei and Liu, Yun and Zhao, Chun-Xia},
title = {DNA Barcoding‐Enabled Tracking of Lipid Nanoparticles: Drug‐Loading‐Dependent Biodistribution and Tumor Microenvironment Targeting},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202501914}
}
EUVIMED